Navigation Links
Catalent Receives P&G External Business Partner of the Year Award
Date:2/19/2019

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has received The Procter & Gamble Company’s (P&G) highest external business partner recognition, the External Business Partner of the Year Award.

The award recognizes the performance of Catalent’s two state-of-the-art softgel manufacturing facilities in Ontario, Canada which have been supplying P&G Personal Healthcare brands in the U.S. and Canada. Catalent also launched additional cough and cold OTC product line extensions with P&G in 2018, which are supplied from Catalent’s facilities in Ontario.

“Catalent has been P&G’s preferred softgel supplier for twenty years,” commented Dr. Aris Gennadios, President, Catalent Softgel Technologies. He added, “We continue to collaborate closely with P&G Personal Healthcare to bring innovative products to consumers.”

“I congratulate and thank all of our award winners. They are critical partners in accomplishing our purpose,” said Stew Atkinson, Chief Purchasing Officer, P&G. “P&G’s supplier eco-systems are creating value for consumers, customers, P&G and our suppliers. I am proud of what we have accomplished, and we will continue to raise the bar on superiority, productivity and citizenship together.”

Catalent’s Ontario facilities in Strathroy and Windsor offer softgel development and manufacturing capabilities for both the pharmaceutical and consumer health industries. The two sites combine integrated formulation, manufacturing, analytical and packaging services to provide full service turnkey solutions to partners.

For more information, please see Procter & Gamble’s press release: https://news.pg.com/press-release/pg-corporate-announcements/pg-recognizes-top-suppliers-powering-global-supply-network-

About Catalent
Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Read the full story at https://www.prweb.com/releases/catalent_receives_p_g_external_business_partner_of_the_year_award/prweb16108054.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes
2. uBiome Receives Patent for Microbiome-Derived Diagnostics and Therapeutics for Immune-Microbial Dysfunction
3. NDA Partners Expert Consultant Vinod Shah, PhD, Receives AAPS Award for Global Leadership
4. EARTHRES Vice President Louis F. Vittorio, Jr., P.G., Receives IBWA Advocacy Award
5. FebriDx® Receives Updated CE Mark to Allow Incorporation of All-in-One Test Format
6. Captiva Spine Receives Clearance to Market TowerLOX-EXT MIS Extended Tab Pedicle Screw
7. EyeLock Receives Patent for Sequentially Linking Iris Matching With Facial Imaging
8. Genos receives CAP Accreditation for Meeting the Highest Standards in Laboratory Practices
9. FST Biometrics Receives a Visionary Award from Frost & Sullivan for Leading the Market in Biometrics-based In Motion Identification
10. SRI International Receives $9 Million Contract to Support National Cancer Institute PREVENT Cancer Program
11. FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2019)... Wis. (PRWEB) , ... May 20, 2019 , ... The ... recruiting trials in gene and cell therapy throughout the United States. Data curated daily ... in a reader-friendly format. , ASGCT members who volunteered to assist in the development ...
(Date:5/21/2019)... ... May 21, 2019 , ... At their May 16 meeting, ... Engineered Medical Products (TEMPs) of the American Society for Testing and Materials International ... Gaining this approval was the next step in the company’s plan to establish its ...
(Date:5/16/2019)... ... May 16, 2019 , ... SFC Fluidics, Inc. ... of the Industry Development and Discovery Partnership that was awarded to SFC Fluidics in ... single integrated pod artificial pancreas (AP) system for people with type 1 diabetes (T1D). ...
Breaking Biology News(10 mins):
(Date:5/8/2019)... ... 2019 , ... Standing at 16.2 hands, Atlas is on the large side for a Quarter ... barrel racing, among other activities. When loping around a corner in late 2017, Atlas ... busy horse to only being able to walk. Fortunately Atlas’ owner, Kelly, sought the ...
(Date:5/4/2019)... ... May 03, 2019 , ... ... of the Diopsys® ffERG/Photopic Negative Response vision test, a new full ... 2050, it is estimated that 6.3 million Americans will have glaucoma, with black ...
(Date:5/2/2019)... , ... May 02, 2019 , ... Stay on top ... medical device and food industries. Access to all webinars is free, so be sure ... in your field! , Visit http://www.xtalks.com to see our upcoming webinars: , ...
(Date:4/25/2019)... ... 2019 , ... Frank is an albino, deaf Great Dane. His owners rescued him when he ... health issues. Despite his hearing impairment, he was always an active and playful pup. Frank ... day, every day. As the two grew, playtime became rougher and Frank ended up injuring ...
Breaking Biology Technology: